TranScrip
Share
TranScrip Partners is a contract organisation that supports biopharmaceutical product development and life cycle management
TranScrip is a trusted partner in providing strategic leadership and operational capacity for over 100 companies globally. Our clients include 20 of the top 50 pharmaceutical and many smaller biopharma companies. TranScrip supports the development and lifecycle management of biopharmaceutical products. We provide expertise, resourcing and strategic oversight from translational medicine to successful registration and market access.
TranScrip and Indegene are pleased to announce the launch of IntraScience's new website http://intrascience.indegene.com/. The website is still work in progress, so make sure to check back regularly for added information...
05/10/2016
After such a successful day up the rigging of a tall ship in 2013, TranScrip decided to do it again! TranScrip staff were joined by their alliance companies and clients. We sailed from Southampton to the Isle of Wight and back and despite the odd light shower of rain, it was a gorgeous sunny day.
The day was made possible by the Tall Ships Trust, which takes over 3,000 people sailing every year on various sailing vessels, and on average over 70% of the Young People are disadvantaged or disabled. TranScrip Partners donated over £5,000 to the Tall Ships Trust, and would like to thank the Trust crew, and the volunteer crew who made this another extremely successful day. For more information on the Tall Ships Trust, please visit their web site at: www.tallships.org and you will see many opportunities to sail with them.
TranScrip's Tim Joslin and Lars Larsson are getting ready for ERS London this weekend. Make sure to catch us there!
ERS (3-7 Sept) is almost upon us and TranScrip will be there. We support all stages of development and commercialisation to maximise market opportunities, reduce risk and achieve commercial success. We would love to update you on how we are expanding, who we have and who we are recruiting or simply just to catch up. If you would like to arrange a meeting at ERS please contact [email protected] or [email protected]
TranScrip’s translational team is strengthened by the appointment of Joseph Chiesa as a Senior Partner. Read the full announcement here… http://www.transcrip-partners.com/news/2016/08/transcrips-translational-medicine-team-is-strengthened-by-the-appointment-of-joseph-chiesa-as-a-senior-partner
TranScrip’s translational medicine team is strengthened by the appointment of Joseph Chiesa as a Senior Partner | News - TranScrip Joseph Chiesa has more than 35 years of experience in the pharmaceutical industry working both for multinational pharmaceutical companies and CROs in the areas of medical affairs, medical research and marketing support. Joseph’s experience spans many therapeutic areas and geographical areas, g...
13/07/2016
Watch part one of TranScrip's Early Clinical Development webcast series by Flic Gabbay and Chris Brearley here http://www.transcrip-partners.com/news/category/commentaries
Following the UK's EU referendum, TranScrip has received many questions on what the impact is likely to be for pharmaceutical and biotech companies on the development and approval of future drugs. The following Q&A summarises TranScrip’s responses to these questions… http://www.transcrip-partners.com/news/category/commentaries
TranScrip are hosting a free event on Evolving Risk-Management Requirements in Early Development on 13th July 2016 at The Nucleus, Chesterford Research Park, Little Chesterford CB10 1XL from 15:00-17.30hrs. Follow the link for further details including registration http://www.onenucleus.com/onenucleus-events?id=1013. We would love to see you there!
We are pleased to announce that the Indegene-TranScrip alliance press release has been selected as one of the One Nucleus BioNewsRound award finalists - results will be announced at the On Helix meeting this afternoon ... http://www.transcrip-partners.com/news/2016/06/transcrips-press-release-selected-as-a-finalist-for-the-one-nucleus-bionewsround-award
TranScrip's Press Release Selected as a Finalist for the One Nucleus BioNewsRound Award | News -... Result to be announced at On Helix meeting at the Wellcome Genome Campus on Monday 27th June
20/06/2016
TranScrip, Indegene and the Drug Safety Research Unit celebrate the launch of IntraScience at the 2nd Pharmacovigilance Conference 2016 in London… http://www.transcrip-partners.com/news/2016/06/transcrip-indegene-and-the-drug-safety-research-unit-celebrate-the-launch-of-intrascience-at-the-2nd-pharmacovigilance-conference-2016-in-london-uk
TranScrip, Indegene and the Drug Safety Research Unit celebrate the launch of IntraScience at... Wednesday 16th June saw the completion of a two day conference on pharmacovigilance in London, devoted to addressing the challenges faced by drug safety departments, especially with the adoption new EU legislation.
The TranScrip team are looking forward to ASM 2016 tomorrow. If you are attending make sure to catch us there!
TranScrip's Tim Joslin reflects on the recent American Thoracic Society 2016 (ATS) conference. Read the full commentary here http://www.transcrip-partners.com/news/category/commentaries